CoChat

Increased Hexosamine Availability Similarly Impairs the Action of Insulin and IGF-1 on Glucose Disposal

Hawkins, Meredith, Barzilai, Nir, Chen, Wei, Angelov, Ivo, Hu, Meizhu, Cohen, Pinchas, Rossetti, Luciano · 1996 · Diabetes
Cited by 46

The DOI matches its Crossref record.

Abstract

Prolonged glucosamine (GlcN) infusion increases the skeletal muscle hexosamine concentration and induces peripheral insulin resistance in conscious rats. IGF-1 and insulin share common steps in signal transduction, and the action of IGF-1 on carbohydrate metabolism is preserved in certain insulin-resistant states. In our study, we attempted to delineate whether increased GlcN availability also impairs the effects of IGF-1 on glucose uptake (Rd), glycolysis, and glycogen synthesis. We performed euglycemic IGF-1 (5 and 15 μg · kg−1 · min−1) and insulin (3 and 18 mU mg · kg−1 · min−1) clamp studies at 0–2 h and 5–7 h in conscious rats (n = 44) during saline or GlcN infusions. GlcN infusion raised plasma GlcN levels to ∼ 2.0 mmol/l and skeletal muscle uridinediphospho-n-acetylglucosamine to 80–150 nmol/g (approximately three- to fivefold over basal). During physiological hyperinsulinemia (3 mU · kg−1 · min−1, plasma insulin ≌ 50 μU/ml), GlcN infusion caused comparable decreases in Rd (15.7 ± 1.0 [5–7 h] vs. 21.7 ± 2.3 [0–2 h] mg · kg−1 · min−1; P < 0.01) and glycogen synthesis (5.4 ± 0.5 [5–7 h] vs. 10.4 ± 1.9 [0–2 h] mg · kg−1 · min−1; P < 0.005). Furthermore, GlcN markedly decreased Rd by 7.8 ± 1.2 mg · kg−1 · min−1 (18.7 ± 0.7 [5–7 h] vs. 26.5 ± 1.3 [0–2 h] mg · kg−1 · min−1; P < 0.001 vs. control) during IGF-1 (5 μg · kg−1 · min−1) clamp studies. This decline was associated with a 26% decrease in the steady-state concentration of skeletal muscle Glc-6-P (286 ± 45 vs. 386 ± 36 nmol/g; P < 0.01) and was primarily caused by impaired glycogen synthesis (6.7 ± 0.5 [5–7 h] vs. 13.9 ± 0.9 [0–2 h] mg · kg−1 · min−1; P < 0.005). The effects of GlcN infusion on glucose disposal (percentage decrease in Rd) were correlated (r2 = 0.803; P < 0.01) with the skeletal muscle concentration of UDP-GlcNAc. To investigate whether IGF-1 can overcome GlcN-induced insulin resistance, GlcN and insulin (18 mU · kg−1 · min−1) were infused for 7 h during euglycemic clamps, and IGF-1 (15 μg · kg−1 · min−1) was superimposed during the final 2 h. GlcN infusion induced severe impairment of insulin action on Rd (39.4 ± 3.2 [4–5 h] vs. 49.8 ± 3.6 [1–2 h] mg · kg−1 · min−1; P < 0.05), which the addition of IGF-1 failed to improve (35.9 ± 2.3 [6–7 h] vs. 39.4 ± 3.2 [4–5 h] mg · kg−1 · min−1; P > 0.1). In summary, GlcN induced severe resistance to the actions of both insulin and IGF-1 on glucose uptake and glycogen synthesis, and IGF-1 was unable to overcome GlcN-induced insulin resistance. Thus, it is likely that GlcN causes peripheral insulin resistance acting at a site common to both IGF-1 and insulin signaling pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diab.45.12.1734

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 46

Metadata

Authors
Hawkins, M., Barzilai, N., Chen, W., Angelov, I., Hu, M., Cohen, P., & Rossetti, L.
Venue
Diabetes
Published
1996-12-01
Volume
45
Issue
12
Pages
1734-1743
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2155614207
Cited by
46
References
0
FWCI
1.11
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased Hexosamine Availability Similarly Impairs the Action of Insulin and IGF-1 on Glucose Disposal. https://app.cochat.ai/papers/10.2337/diab.45.12.1734
The paper
Hawkins, M., Barzilai, N., Chen, W., Angelov, I., Hu, M., Cohen, P., & Rossetti, L. (1996). Increased Hexosamine Availability Similarly Impairs the Action of Insulin and IGF-1 on Glucose Disposal. Diabetes. https://doi.org/10.2337/diab.45.12.1734

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.